Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Bayer Finally Closes Topsun Acquisition

publication date: Jul 3, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Bayer HealthCare announced that its China subsidiary has finally received regulatory approval to complete its acquisition of Topsun's OTC cough and cold portfolio. The takeover has been under way for a long time: it was originally announced in October 2006, and ChinaBio® Today reported five months ago that the deal received a last-minute reprieve only after a technical breach of its drop-dead date. More details...

Stock Symbols: (XE: 575200) (SHA: 600771)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...